News
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
Discover which celebrities like Whoopi Goldberg and Renee Graziano have opened up about using Mounjaro for weight loss and ...
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...
Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...
Blocking Mitch, a protein that regulates energy control, prevents fat from accumulating in human cells. About a decade ago, a ...
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...
Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...
Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results